Art Sedrakyan   Professor of Healthcare Policy and Research in Cardiothoracic Surgery

Art Sedrakyan is a Professor at Weill Cornell Medical College and is also leading US Food and Drug Administration’s (FDA) Medical Device Epidemiology (MDEpiNet) Science and Infrastructure Center and leads the Coordinating Center activities  see main
At Cornell he also directs patient centered comparative outcomes research center for devices and interventions/surgery.

He is a trained CT surgeon and a graduate of Johns Hopkins University with Ph.D in Health Policy and Management He was a senior adviser at FDA and had appointments as senior service officer/senior adviser at the Agency for Healthcare Research and Quality (AHRQ) from 2005 to 2009. He was a lead adviser on interventions (including surgery), implantable devices and cardiovascular and orthopedic content areas. He was one of initiators of the Effective Healthcare Cardiovascular Consortium and supervised centers for Education and Research in Therapeutics (CERTS); Cardiovascular CERT and orthopedic Device CERT.

Prior to appointments at DHHS he worked in the United Kingdom and has registry research, evidence synthesis and teaching experience from Royal College of Surgeons (RCS) of England and London School of Hygiene (LSHTM), where he served as a faculty and was Senior Adviser for National Collaborating Center for Acute Care (part of UK National Institute of Clinical Excellence (NICE)).

He is currently serving as a ranking member and was previously the Vice-Chair of Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). He is serving on MEDCAC from June 1, 2010. Dr. Sedrakyan is the Vice-Chair of the IDEAL initiative with special interest/leadership area in devices ( The IDEAL is the main international organization dealing with technology innovation and its evaluation. Since January 2017 he is serving as specialist advisor for Australian Therapeutic Good Administration (TGA) and Honorary Professor at the Australian National University where he established health services research group.

Dr. Sedrakyan is the initiator (with FDA) and principal investigator of the FDA’s International Consortium of Orthopedic Registries (ICOR,, International Consortium of Cardiac Registries (ICCR) and International Consortium of Vascular Registries (ICVR, and national coordinated registry network (CRN) efforts in these areas. He is also facilitating registry development for robotic and high frequency ultrasound technologies.

These national and international initiatives aim to advance the infrastructure for regulatory science, surveillance and comparative effectiveness for medical devices and interventions. The registry and other big data such as claims revolutionize the health services research and approach to quality and efficiency improvement in care.

He has over 150 publications and is frequently publishing in BMJ, JAMA, Lancet and high impact surgical journals. PubMed link:


Sort by

Selected publications


Sort by

Grants awarded



Primary Email